바이오테크 보도자료
-
- Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
- Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase...
- 2023년 06월 21일
-
- Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
- Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM:HCM, HKEX:13) (HUTCHMED) today announced that results of the Phase 3 FRESCO2 study evaluating fruquintinib in patients with previously trea...
- 2023년 06월 18일
-
- SciMed (Asia), Life Science Sales and Service Distributing Subsidiary of PHC Holdings Corporation, Becomes Wholly Owned Subsidiary -- Acquisition Expands PHC Group’s Business Supporting Researchers and Healthcare Providers in Asia-Pacific --
- PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President, Representative Director and CEO: Shoji Miyazaki, hereafter PHCHD) announces that it has acquired the remaining 30% stake in its sub...
- 2023년 06월 16일
-
- Takeda and HUTCHMED Announce Marketing Authorization Application of Fruquintinib for Previously Treated Metastatic Colorectal Cancer Validated by the European Medicines Agency
- Takeda (TSE:4502/NYSE:TAK) and HUTCHMED (China) Limited (Nasdaq/AIM: HCM, HKEX: 13) (HUTCHMED) today announced that the European Medicines Agency (EMA) has validated and accepted for regulatory review the ma...
- 2023년 06월 16일
-
- Ferring Pharmaceuticals successfully increases its second Swiss Franc Bond offering by CHF 80 million
- Ad hoc announcement pursuant to Art. 53 LR Ferring Pharmaceuticals announced the successful increase of its second Swiss Franc Bond offering by CHF 80 million. This senior unsecured bond transaction is issue...
- 2023년 06월 16일
-
- First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
- With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned in a Phase I clinical trial[2] of a first-of-its kind fluor...
- 2023년 06월 15일
-
- Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
- Today, Organon (NYSE:OGN), a global healthcare company focused on women’s health, and CAF, Development Bank of Latin America, signed a memorandum of understanding (MOU) to contribute to the United Nations Su...
- 2023년 06월 08일
-
- Falcon 40B: World’s Top AI Model Rewards Most Creative Use Cases in Call for Proposals with Training Compute Power
- Falcon 40B, the world’s top-ranked open-source AI model on the Hugging Face leaderboard for large language models (LLMs), is registering an overwhelming response to a Call for Proposals from scientists, rese...
- 2023년 06월 08일
-
- OSARO SightWorks Vision Software Now Available for Systems Integrators, 3PLs, and E-Commerce Fulfillment Operators
- OSARO®, a global leader in machine-learning-enabled robotics for e-commerce, announced that OSARO SightWorks™, its advanced vision software for picking, depalletizing, induction, kitting, and other automated...
- 2023년 06월 08일
-
- Carbios Aims to be a Leader in Growing r-PET Market with an Ambition to Capture 8 to 12% Share by 2035 Through Licensing Model
- Regulatory News: Carbios (Euronext Growth Paris: ALCRB), a biotech company pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, will...
- 2023년 06월 07일
-
- Arthur D. Little: Companies Miss Out on Boosting Their Innovation Return on Investment by, on Average, 30%
- Arthur D. Little (ADL) today launched its 2023 Global Innovation Management Excellence Benchmark Report, which highlights that of the $2 trillion per year that companies invest in R&D, financial returns from...
- 2023년 06월 07일
전시회
